Elevation Oncology Announces Appointment of Joseph Ferra as Chief Financial Officer

NEW YORK, June 17, 2021 /PRNewswire/ — Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, announced today the appointment of Joseph Ferra as the company’s Chief Financial Officer….

About the Author

has written 20663 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com